FDA Inspection 1301400 — Marsh Regional Blood Center
The FDA completed an inspection of Marsh Regional Blood Center on January 15, 2026 in Bristol, TN. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Biologics.
Inspection Details
- Classification
- No Action Indicated (NAI) (NAI)
- End Date
- January 15, 2026
- Fiscal Year
- 2026
- Product Type
- Biologics
- Project Area
- Blood and Blood Products
- Location
- Bristol, TN (United States)